Insilico Medicine Hong Kong Limited

This early-stage study tests a new drug called ISM3412 in about 80 adults whose advanced solid tumors have not responded to standard treatments. The main goals are to check safety, find the best dose, and see if the drug can shrink tumors. Participants must have a specific geneti…

This study tests a new drug called ISM5411 for adults with active ulcerative colitis, a condition causing inflammation in the colon. About 80 participants will receive either the drug or a placebo to check safety and how well it works. The goal is to control the disease, not cure…

This study tests an oral drug called INS018_055 in 40 adults with idiopathic pulmonary fibrosis (IPF), a lung-scarring disease. The main goal is to check the drug's safety over 12 weeks. Participants are randomly assigned to receive the drug or a placebo.

This early-phase study tests an experimental drug called ISM6331 in people with advanced mesothelioma or other solid tumors that have not responded to standard treatments. The main goals are to check the drug's safety, find the best dose, and see if it can shrink tumors. About 10…